- Home
- TRIB vs BCTX Comparison
TRIB vs BCTX Comparison
Compare TRIB & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- BCTX
- Stock Information
- Founded
- TRIB 1992
- BCTX 2014
- Country
- TRIB Ireland
- BCTX Canada
- Employees
- TRIB N/A
- BCTX N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- BCTX Health Care
- Exchange
- TRIB Nasdaq
- BCTX Nasdaq
- Market Cap
- TRIB 18.3M
- BCTX 18.5M
- IPO Year
- TRIB N/A
- BCTX N/A
- Fundamental
- Price
- TRIB $0.95
- BCTX $10.20
- Analyst Decision
- TRIB
- BCTX Strong Buy
- Analyst Count
- TRIB 0
- BCTX 1
- Target Price
- TRIB N/A
- BCTX $40.00
- AVG Volume (30 Days)
- TRIB 67.0K
- BCTX 45.0K
- Earning Date
- TRIB 11-14-2025
- BCTX 12-15-2025
- Dividend Yield
- TRIB N/A
- BCTX N/A
- EPS Growth
- TRIB N/A
- BCTX N/A
- EPS
- TRIB N/A
- BCTX N/A
- Revenue
- TRIB $61,555,000.00
- BCTX N/A
- Revenue This Year
- TRIB $13.51
- BCTX N/A
- Revenue Next Year
- TRIB $13.14
- BCTX $380.95
- P/E Ratio
- TRIB N/A
- BCTX N/A
- Revenue Growth
- TRIB 8.31
- BCTX N/A
- 52 Week Low
- TRIB $0.48
- BCTX $6.00
- 52 Week High
- TRIB $3.44
- BCTX $190.50
- Technical
- Relative Strength Index (RSI)
- TRIB 56.27
- BCTX 53.94
- Support Level
- TRIB $0.80
- BCTX $6.93
- Resistance Level
- TRIB $0.94
- BCTX $11.54
- Average True Range (ATR)
- TRIB 0.08
- BCTX 0.86
- MACD
- TRIB 0.01
- BCTX 0.05
- Stochastic Oscillator
- TRIB 72.73
- BCTX 74.99
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.